ALSE
Price:
$0.01
Market Cap:
$398.25K
Alseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is based in Auburndale, Massachusetts.
Industry
Biotechnology
IPO Date
1994-12-22
Stock Exchange
OTC
Ticker
ALSE
According to Alseres Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 5.04%. This represents a change of 311.02% compared to the average of 1.23% of the last 4 quarters.
The mean historical ROE of Alseres Pharmaceuticals, Inc. over the last ten years is -177.89%. The current 5.04% ROE has changed -102.83% with respect to the historical average. Over the past ten years (40 quarters), ALSE's ROE was at its highest in in the September 2006 quarter at 167.19%. The ROE was at its lowest in in the June 2006 quarter at -354.04%.
Average
-177.89%
Median
9.13%
Minimum
-1977.54%
Maximum
159.03%
Discovering the peaks and valleys of Alseres Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.76%
Maximum Annual ROE = 159.03%
Minimum Annual Increase = -969.06%
Minimum Annual ROE = -1977.54%
| Year | ROE | Change |
|---|---|---|
| 2013 | 8.84% | 43.54% |
| 2012 | 6.16% | -34.63% |
| 2011 | 9.42% | -969.06% |
| 2010 | -1.08% | -104.78% |
| 2009 | 22.68% | -56.46% |
| 2008 | 52.10% | -40.26% |
| 2007 | 87.21% | -45.16% |
| 2006 | 159.03% | -209.12% |
| 2005 | -145.74% | -92.63% |
| 2004 | -1977.54% | 2.76% |
The current ROE of Alseres Pharmaceuticals, Inc. (ALSE) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
8.14%
5-year avg
9.20%
10-year avg
-177.89%
Alseres Pharmaceuticals, Inc.’s ROE is less than Achiko AG (215.86%), greater than Lotus Ventures Inc. (-18.63%), greater than Evolva Holding S.A. (-13.27%), greater than FluroTech Ltd. (-1180.16%), greater than Digicann Ventures Inc. (-17491.11%), greater than TuHURA Biosciences, Inc. (-393.18%), greater than Phoenix Life Sciences International Limited (-71.46%), less than Aquarius Surgical Technologies Inc. (4.41%), less than Kiromic BioPharma, Inc. (231.14%), greater than Hemogenyx Pharmaceuticals Plc (-141.83%),
| Company | ROE | Market cap |
|---|---|---|
| 215.86% | $377.40K | |
| -18.63% | $458.85K | |
| -13.27% | $518.24K | |
| -1180.16% | $447.18K | |
| -17491.11% | $357.36K | |
| -393.18% | $100.77M | |
| -71.46% | $365.91K | |
| 4.41% | $293.32K | |
| 231.14% | $214.93K | |
| -141.83% | $13.79M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alseres Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alseres Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Alseres Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Alseres Pharmaceuticals, Inc. (ALSE)?
What is the highest ROE for Alseres Pharmaceuticals, Inc. (ALSE)?
What is the 3-year average ROE for Alseres Pharmaceuticals, Inc. (ALSE)?
What is the 5-year average ROE for Alseres Pharmaceuticals, Inc. (ALSE)?
How does the current ROE for Alseres Pharmaceuticals, Inc. (ALSE) compare to its historical average?